Variant report

Variant	rs3213345
Chromosome Location	chr19:44060475-44060476
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr19:44058393..44061505-chr19:44095706..44100146,4	MCF-7	breast:
2	chr19:44059185..44060976-chr19:44078373..44080974,2	K562	blood:
3	chr19:44059581..44061634-chr19:44072814..44074549,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000073050	Chromatin interaction
ENSG00000234465	Chromatin interaction
ENSG00000167378	Chromatin interaction
ENSG00000268361	Chromatin interaction
ENSG00000269583	Chromatin interaction

Extended variants
information (count: 25 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:13)

rs_ID	r²[population]
rs10415683	1.00[AMR][1000 genomes]
rs11666646	1.00[LWK][hapmap]
rs2307184	1.00[LWK][hapmap]
rs28430973	1.00[AMR][1000 genomes]
rs3213241	1.00[AMR][1000 genomes]
rs3213292	1.00[AMR][1000 genomes]
rs3213355	1.00[AMR][1000 genomes]
rs3213357	1.00[ASW][hapmap];1.00[YRI][hapmap];1.00[AMR][1000 genomes]
rs3213390	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs3213392	1.00[AMR][1000 genomes]
rs4251953	1.00[YRI][hapmap]
rs58434293	0.93[AFR][1000 genomes]
rs60602121	0.93[AFR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1055872	chr19:43173614-44075193	Strong transcription Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
2	nsv544009	chr19:43173614-44075193	Enhancers ZNF genes & repeats Genic enhancers Active TSS Weak transcription Strong transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
3	nsv1067126	chr19:43260649-44075194	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	41 gene(s)	inside rSNPs	diseases
4	nsv544015	chr19:43260649-44075194	Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	41 gene(s)	inside rSNPs	diseases
5	nsv1057657	chr19:43302497-44076564	Strong transcription Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
6	nsv1059631	chr19:43316978-44075054	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
7	nsv544030	chr19:43316978-44075054	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
8	nsv532820	chr19:43807486-44080610	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
9	nsv1056721	chr19:43808474-44095077	Strong transcription Weak transcription Active TSS Flanking Active TSS Enhancers ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
10	nsv532821	chr19:43842383-44357315	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	62 gene(s)	inside rSNPs	diseases
11	nsv1056785	chr19:44010370-44081601	Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases
12	nsv1063149	chr19:44059081-44087583	Weak transcription Strong transcription Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:124 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:44039200-44078600	Weak transcription	Hela-S3	cervix
2	chr19:44040800-44060800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
3	chr19:44041800-44065200	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
4	chr19:44043200-44064600	Weak transcription	NHDF-Ad	bronchial
5	chr19:44043600-44065800	Strong transcription	Adipose Nuclei	Adipose
6	chr19:44043800-44065800	Weak transcription	Fetal Heart	heart
7	chr19:44043800-44074000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr19:44044600-44069000	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr19:44045200-44062800	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr19:44047400-44066600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr19:44048200-44062000	Weak transcription	NH-A	brain
12	chr19:44048200-44067000	Weak transcription	HUVEC	blood vessel
13	chr19:44048400-44078800	Weak transcription	Small Intestine	intestine
14	chr19:44050400-44063000	Strong transcription	Thymus	Thymus
15	chr19:44052600-44060600	Strong transcription	Osteobl	bone
16	chr19:44052800-44068400	Strong transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr19:44053000-44064800	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr19:44053000-44065600	Strong transcription	Primary neutrophils fromperipheralblood	blood
19	chr19:44053000-44066200	Strong transcription	Fetal Muscle Leg	muscle
20	chr19:44053200-44064600	Weak transcription	K562	blood
21	chr19:44053400-44061000	Strong transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
22	chr19:44053400-44068800	Strong transcription	Fetal Intestine Small	intestine
23	chr19:44053400-44069400	Strong transcription	Fetal Stomach	stomach
24	chr19:44053600-44062400	Strong transcription	Dnd41	blood
25	chr19:44053600-44068600	Strong transcription	Fetal Intestine Large	intestine
26	chr19:44053800-44060600	Strong transcription	Breast Myoepithelial Primary Cells	Breast
27	chr19:44053800-44060600	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr19:44053800-44062600	Strong transcription	Ganglion Eminence derived primary cultured neurospheres	brain
29	chr19:44054000-44065600	Strong transcription	Placenta	Placenta
30	chr19:44054200-44061200	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr19:44054400-44062400	Strong transcription	Primary T cells from cord blood	blood
32	chr19:44054400-44062400	Strong transcription	Skeletal Muscle Female	skeletal muscle
33	chr19:44054600-44061200	Strong transcription	Rectal Mucosa Donor 31	rectum
34	chr19:44054600-44062400	Strong transcription	HSMM	muscle
35	chr19:44055200-44061000	Strong transcription	Fetal Adrenal Gland	Adrenal Gland
36	chr19:44056000-44066600	Weak transcription	Psoas Muscle	Psoas
37	chr19:44056400-44064600	Weak transcription	Aorta	Aorta
38	chr19:44056400-44064800	Weak transcription	H9 Cell Line	embryonic stem cell
39	chr19:44056400-44066400	Weak transcription	Stomach Mucosa	stomach
40	chr19:44057200-44067000	Weak transcription	Fetal Brain Male	brain
41	chr19:44057400-44060800	Strong transcription	GM12878-XiMat	blood
42	chr19:44057600-44061800	Weak transcription	Liver	Liver
43	chr19:44057600-44061800	Weak transcription	Rectal Smooth Muscle	rectum
44	chr19:44057600-44071200	Weak transcription	Pancreatic Islets	Pancreatic Islet
45	chr19:44057800-44078800	Weak transcription	HSMMtube	muscle
46	chr19:44058000-44062800	Strong transcription	Stomach Smooth Muscle	stomach
47	chr19:44058200-44064800	Weak transcription	NHEK	skin
48	chr19:44058400-44061000	Weak transcription	Brain Inferior Temporal Lobe	brain
49	chr19:44058400-44062200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr19:44058400-44063800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links